Endpoint Health
W19
Active

Endpoint Health

Precision-first therapies

Endpoint Health is on a mission to address urgent needs in immune-driven critical and chronic illnesses by delivering therapies that are personalized to each patient’s biology. We built Endpoint Health from the ground up to develop and commercialize therapeutics and therapy-guiding tests, to ensure that every patient receives personalized treatment that will dramatically improve their outcomes. Our vision is a world in which all patients have effective, personalized treatment, because therapies are targeted to the right patient at the right time.

Diego Rey, CSO

Diego is currently co-founder, board member, and Chief Scientific Officer of Endpoint Health a targeted therapeutics company in critical care. Prior to Endpoint, Diego co-founded GeneWEAVE, a diagnostics company that develops diagnostic products for detecting infections and guiding antibiotic therapy. Started in 2010, GeneWEAVE raised $25M in venture financing and was acquired by Roche in 2015 for $425M. Diego is also a former visiting partner and currently an bio Expert at YC.

Jeff Osborn

Jeff Osborn
Jeff Osborn
Endpoint Health

Jason Springs

Jason Springs
Jason Springs
Endpoint Health

Leonardo Teixeira

Leonardo Teixeira
Leonardo Teixeira
Endpoint Health